In the recent study, Radiotherapy Delivered Before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer, researchers compared various forms of treatment including radiotherapy, oral palbociclib, or a combination of both. Researchers found that radiotherapy delivered before CDK4/6 inhibitors mediated superior antineoplastic effects compared with alternative treatment schedules. See more below, and the full study here.
Reaching Out to Improve Access to Radiation Therapy
Reaching Out to Improve Access to Radiation Therapy Treatment: Xstrahl attends regional conferences to meet with clinicians and discuss radiation therapy
